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Abstract
Introduction: We and others demonstrated previously that preconditioning with endotoxin (LPS) protected from a
subsequent lethal LPS challenge or from renal ischemia-reperfusion injury (IRI). LPS is effective in evoking the heat shock
response, an ancient and essential cellular defense mechanism, which plays a role in resistance to, and recovery from
diseases. Here, by using the pharmacological Hsp90 inhibitor novobiocin (NB), we investigated the role of Hsp90 and the
heat shock response in LPS-induced delayed renal preconditioning.
Methods: Male C57BL/6 mice were treated with preconditioning (P: 2 mg/kg, ip.) and subsequent lethal (L: 10 mg/kg, ip.)
doses of LPS alone or in combination with NB (100 mg/kg, ip.). Controls received saline (C) or NB.
Results: Preconditioning LPS conferred protection from a subsequent lethal LPS treatment. Importantly, the protective
effect of LPS preconditioning was completely abolished by a concomitant treatment with NB. LPS induced a marked heat
shock protein increase as demonstrated by Western blots of Hsp70 and Hsp90. NB alone also stimulated Hsp70 and Hsp90
mRNA but not protein expression. However, Hsp70 and Hsp90 protein induction in LPS-treated mice was abolished by a
concomitant NB treatment, demonstrating a NB-induced impairment of the heat shock response to LPS preconditioning.
Conclusion: LPS-induced heat shock protein induction and tolerance to a subsequent lethal LPS treatment was prevented
by the Hsp90 inhibitor, novobiocin. Our findings demonstrate a critical role of Hsp90 in LPS signaling, and a potential
involvement of the heat shock response in LPS-induced preconditioning.
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Introduction
Acute kidney injury (AKI) is a leading cause of death in the
intensive care units. The incidence of AKI may exceed that of
stroke [1] and even if patients survive there is a high risk of
developing or exacerbating chronic kidney disease (CKD) [1,2].
The main cause of AKI is ischemia-reperfusion injury (IRI)-
induced acute tubular necrosis (ATN) [3,4]. The kidney is an
important shock organ, often being responsible for the death of
septic patients. Sepsis is the most common cause of AKI in
critically ill patients [5]. In septic patients bacterial lipopolysac-
charide (endotoxin, LPS) can significantly contribute to AKI [6,7].
Currently there are no effective therapeutic strategies to reduce
AKI [8]. Delayed preconditioning is an attractive method to
reduce IRI of different organs, such as the heart, brain or kidney.
A better understanding of the molecular mechanisms behind
delayed preconditioning could enable the development of new
therapeutic strategies to pharmacologically induce tissue resistance
to AKI.
Delayed preconditioning elicited by a stressful stimulus
promotes survival by increasing tolerance to a subsequent lethal
stress. Preconditioning LPS treatment prevents death from a
subsequent lethal LPS dose [9]. Moreover, the endotoxin-induced
cross-tolerance to IRI has been described in the heart [10] and
brain [11]. Based on this principle, we have previously established
a model for delayed-type LPS cross-tolerance to renal IRI. We
demonstrated that LPS was capable of inducing delayed precon-
ditioning, and protected from a subsequent lethal LPS dose or
lethal renal IRI [12]. Mechanisms of this delayed cross-tolerance
have been investigated since then [13,14]. Molecular interactions
between renal IRI and LPS have been also demonstrated at the
mRNA level [15]; however, the exact mechanism of LPS-induced
delayed preconditioning remains unclear.
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The heat shock response is an ancient and essential cellular
survival mechanism that operates via a heat shock transcription
factor 1 (HSF1)-dependent induction of heat shock proteins
(HSPs). The major heat shock proteins, such as Hsp70 and Hsp90
confer tolerance to a plethora of stresses by maintaining the
conformational homeostasis and exerting anti-apoptotic effects
[16,17]. Besides, Hsp90 plays specific roles, such as keeping HSF1
in an inactive form, and chaperoning various signaling molecules.
Along with Hsp70 Hsp90 mediates LPS-signaling as a part of the
LPS receptor cluster [18–20]. The Hsp90 function involves ATP-
binding and hydrolysis coordinated by the N- and C-terminal
domains of the chaperone [21]. N-terminal Hsp90 inhibitors,
exemplified by geldanamycin, are promising anti-cancer agents,
currently in clinical trials [22]. They potently induce the heat
shock response, which is a major drawback in antitumor therapy
but are extensively utilized in a number of degenerative diseases
such as ischemic diseases and organ transplantation [17,23]. It has
also been demonstrated that geldanamycin protects renal cells
from oxidative stress and reduce renal ischemia-reperfusion injury
[24,25]. In contrast, the coumarin antibiotic novobiocin (NB), a C-
terminal Hsp90 antagonist inhibits Hsp90 function without
induction of the heat shock response [22,26,27]. Utilizing these
excellent properties of NB, we applied NB treatment to study the
involvement of Hsp90 and the heat shock response in LPS-
induced delayed preconditioning in mice.
Our results demonstrate that the Hsp90 inhibitor NB
completely prevented LPS-induced delayed preconditioning to
lethal LPS administration in mice. Besides, NB prevented the
induction of Hsp70 and Hsp90 protein induction in response to
LPS. Thus, our data support a critical role of Hsp90 and the heat
shock response in endotoxin-tolerance, but also warn that Hsp90
inhibition with novobiocin may be deleterious in sepsis.
Methods
Ethics Statement
By survival studies humane endpoints were used to minimize
suffering. Animals were observed and weighed after potentially
lethal interventions including LPS regimen every morning. In case
clinical signs of distress were recognized, the animals were
euthanized by cervical dislocation performed by the PI trained
in this technique. Clinical signs of endotoxin shock included
reduced locomotion, signs of diarrhea, piloerection and a body
weight loss exceeding 40% of the initial body-weight or a
reduction below 18 g. All intraperitoneal injections and sacrifice
for organ removal were performed under ether anesthesia. The
protocol was reviewed and approved by the Governmental Animal
Care Agency and the Research Committee Board of Semmelweis
University 53/2001. (V.31.) ET.).
Animals
Male C57BL/6 mice (Charles River, Germany) weighing
27.661.8 g were used. All animals were housed under standard
specified pathogen-free conditions (light on 08:00–20:00 h; ambi-
ent relative humidity: 40–70%, 2261uC), and had free access to
tap water and chow (Altromin standard diet, Germany). After 1
week of acclimatization mice were randomized into eight
experimental groups with similar average body weight at inclusion.
Treatments
Mice were treated intraperitoneally (ip.) under short ether
(diethyl-ether, Reanal, Budapest, Hungary) anesthesia. Novobio-
cin (Promega, WI, USA) dose was 100 mg/kg. The precondition-
ing dose of LPS (Escherichia coli, Serotype 0111:B4; Sigma-
Aldrich, Budapest, Hungary) was 2 mg/kg and the lethal dose of
LPS was 10 mg/kg (ip.) as previously established by us [12]. The
animals were treated on 2 consecutive days (Table 1). Survival was
observed in five animals in each treatment group. Another five
animals in each group were sacrificed for the determination of
renal HSP expression.
Detection of renal damage by plasma urea concentration
Renal function was evaluated by determination of urea
retention at the time of organ harvesting. Blood urea levels were
measured from 32 ml of whole blood with ReflotronH Urea test
stripes (Roche Diagnostics GmbH, Mannheim, Germany) on the
ReflotronH Plus device (Roche) following the manufacturer’s
protocol.
Organ harvest
Animals were sacrificed 24 hours after the second treatment.
Harvest began with ether anesthesia and injection of heparin
(500 U/animal ip., Heparin Biochemie GmbH, Schaftenau,
Austria) of mice. Blood was removed from parenchymal organs
by injection of 20 ml ice cold Hank’s Buffered Salt Solution
(Sigma-Aldrich, Budapest, Hungary) through the left ventricle
using a 20 ml syringe and an 18 G needle. Following perfusion,
kidneys were removed and the upper pole of each kidney was fixed
in 4% buffered formalin for one day, and then were dehydrated
and embedded in paraffin (FFPE) for morphological analysis. The
lower pole was snap frozen in liquid nitrogen and kept at 280uC
for molecular investigations.
Histological analysis
Four mm thick FFPE sections were deparaffinized, rehydrated
and consecutively stained with haematoxylin and eosin (H&E) and
periodic acid Shiff (PAS). Sections were examined in a blinded
fashion. All photomicrographs were taken with Leica DC500
microscope.
The extent of ischemic renal damage was estimated using a
previously published scoring system [12]. Severity of tubular injury
was determined by changes of nucleus morphology, tubular cell
vacuolization, detachment or hyalinization. Periodic acid Schiff
(PAS) stained kidney samples were scored under x200 absolute
magnification, and a score from 0 to 3 was given for each tubular
profile per field of view: 0 = normal histology; 1 = tubular cell
swelling, mild-moderate brush border damage, vacuolization of
tubular epithelial cells; 2 = moderately dilated tubules, more
severe brush border loss, edematous tubular epithelial cells, focally
Table 1. Treatment protocols for LPS preconditioning.
Group Day 1 Day 2
Saline 0.1 ml/10 g saline 0.1 ml/10 g saline
NB 0.1 ml/10 g saline 100 mg/kg NB
LPS(p) 2 mg/kg LPS 0.1 ml/10 g saline
LPS(p+L) 2 mg/kg LPS 10 mg/kg LPS
LPS(p)+ NB 2 mg/kg LPS 100 mg/kg NB
LPS(L) 0.1 ml/10 g saline 10 mg/kg LPS
NB+ LPS(L) 100 mg/kg NB 10 mg/kg LPS
LPS/NB+ LPS(L) 2 mg/kg LPS +100 mg/kg NB 10 mg/kg LPS
Saline: physiological saline, LPS: bacterial lipopolysaccharide endotoxin, p:
preconditioning dose, L: lethal dose, NB: novobiocin.
doi:10.1371/journal.pone.0092004.t001
Hsp90-Dependent LPS Preconditioning in Mouse Kidney
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weak/lost nuclear staining; 3 = total tubular necrosis, neutrophil
granulocyte infiltration, no nuclear staining, dilated tubules with or
without tubular cast formation in the lumen. Mean values were
calculated from 10 fields of view.
Kidney Hsp70, Hsp90a, Hsp90b and a-actin protein and
mRNA expression
Kidney samples were snap-frozen in liquid nitrogen and stored
at 280uC until use. Protein and mRNA of Hsp70 and Hsp90a
and Hsp90b were determined by Western and Northern blotting,
respectively.
RNA extraction and Northern Blot Analysis
Samples were homogenized in TRIzol (Life Technologies,
Gaithersburg, MD, USA), extracted with phenol-chloroform, and
the RNA was precipitated with isopropanol. Total RNA (12 mg)
was electrophoresed through a 1% formaldehyde-agarose gel and
transferred to a Nytran membrane (Schleicher & Schuell, Keene,
NH, USA). The membrane was ultraviolet cross-linked, baked at
80uC for 2 h, and hybridized for 1 h with Hybrisol I (Oncor,
Gaithersburg, MD, USA). The following cDNAs were used:
mouse Hsp70 detecting both Hsp72 and Hsc70 (Hsp73), (Kerstin
Bellmann, Heinrich-Heine University, Du¨sseldorf, Germany),
Hsp90a (kind gift of Yoshihiko Miyata, Kyoto University, Japan)
and Hsp90b (kind gift of Attila Sebe, Semmelweis University,
Institute of Pathophysiology, Hungary), and human S14 ribosomal
protein (plasmid no. 59247, American Type Culture Collection,
Manassas, VA, USA) as a housekeeping gene. The Hsp70 and
Hsp90 plasmids were PCR amplified (ICycler, Bio-Rad Hercules,
CA, USA), run on an agarose gel to excise the amplicon. DNA was
isolated (GeneElute Kit, Sigma-Aldrich, Budapest, Hungary) and
inserted into a plasmid with InsTAclone PCR Product Cloning
Kit (Fermentas, St. Leon-Rot, Germany). All plasmids were
amplified in E. Coli and were isolated with the cesium chloride
density gradient ultracentrifugation method [28], and the cDNA
was excised. The cDNA inserts were labeled with 32P-dCTP
(Amersham, Arlington Heights, IL, USA), using the Prime It II
random prime labeling kit (Stratagene, La Jolla, CA, USA). The
membranes were hybridized overnight at 42uC, and washed with
PES buffer (40 mM sodium phosphate, pH 7.4, 1 mM ethylene-
diamine-tetra-acetic acid, 0.5% sodium dodecyl sulfate) twice at
room temperature for 15 min and once at 55uC for 15 min. The
radioactive signal was detected and quantified using a Phosphor
Imager Molecular Imager FX (Bio-Rad, Hercules, CA, USA).
Protein preparation and Western blotting
For Western blotting analysis the excised specimens were
immediately dropped into liquid nitrogen. Western blotting was
performed as described previously [29]. Briefly, frozen tissue
samples were homogenized in ice-cold lysis buffer in 15 ml
centrifuge tubes by a mechanical homogenizer. The lysis buffer
contained 25 mM Tris (pH 7,4), 1% NP-40, 100 mM NaCl,
4 mM EDTA, 1 mM NaVO4, 10 mM NaF, 1 mM DTT (all
chemicals were purchased from Sigma-Aldrich, Budapest, Hun-
gary) and supplemented with 50x protease inhibitor cocktail (BD
Biosciences Pharmingen, San Diego, CA, USA). Protein concen-
trations were determined by the Bradford method. Tissue lysates
were mixed 1:1 with 2x Laemmli sample buffer and boiled for
5 min at 95uC. Equal amounts of protein for each sample were
loaded onto 9% polyacrylamide gels (Bio-Rad, Hercules, CA,
USA), separated by SDS-PAGE, and transferred to nitrocellulose
membranes (Bio-Rad, Hercules, CA, USA). The membranes were
blocked with 5% non-fat dry milk and incubated with a
monoclonal anti-Hsp72 (Stressgen Biotechnologies, Victoria,
Canada), polyclonal anti-Hsp90 (recognizing both the alpha and
beta isoforms (kind gift of Yoshihiko Miyata, Kyoto University,
Kyoto, Japan) and a-aktin (Sigma-Aldrich, Budapest, Hungary)
antibodies and HRP-conjugated secondary antibodies. The
membranes were developed with an enhanced chemiluminescence
detection system (PerkinElmer, Wellesley, MA, USA) and
analyzed by densitometry.
Statistical analysis
All continuous data are expressed as mean+SD unless otherwise
stated. Comparisons among groups used one-way analysis of
variance (ANOVA) followed by Tukey’s multiple comparisons test
for between-groups comparisons. The Kruskal–Wallis one-way
analysis of variance by ranks was performed if Bartlett’s test
indicated heterogeneity of variances, and comparisons between
groups used Dunn’s test. Nonparametric data were tested using
Mann-Whitney analysis of ranks. Survival curves were compared
by Kaplan- Meyer log-rank test. All tests were conducted at the
two-sided 5% significance level. Statistical analysis was performed
using GraphPad Prism5 (GraphPad Software Inc., San Diego, CA,
USA).
Results
Novobiocin reversed the preconditioning-induced
survival from lethal LPS shock
First, we investigated how inhibition of Hsp90 with novobiocin
(NB) influenced LPS-induced preconditioning in male mice
(Figure 1). All mice treated with saline, or NB without LPS or a
preconditioning dose of LPS (LPS(p)) survived. However, all mice
died within one week after treatment with a lethal dose of LPS
(LPS(L)) (p,0.01 vs. saline). Preconditioning with LPS prevented
death from a subsequent lethal LPS dose as only one animal died
in this group (LPS(p+L)) (p,0.01 vs. LPS(L)). However, pretreat-
ment with NB (LPS/NB+LPS(L)) prevented the preconditioning
effect of LPS(p) as all mice died in this group (p,0,01 vs. LPS(p)).
Thus, NB prevented delayed preconditioning (Figure 1). Further-
more, NB sensitized to LPS to some extent as two animals also
died after treatment with LPS(p) and NB (LPS(p)+NB) (ns).
Figure 1. Survival. The control group treated with saline (saline) is
represented with filled circles and solid line, the group treated with
novobiocin (NB) is represented with filled squares and solid line, the
groups treated with LPS are represented with triangles and dashed line
(LPS(p)), solid line (LPS(L)) and dotted line (LPS(p+L)), the groups treated
with LPS + NB are represented with diamonds and solid line (NB +
LPS(L)) and dotted line (LPS/ND + LPS(L)).
doi:10.1371/journal.pone.0092004.g001
Hsp90-Dependent LPS Preconditioning in Mouse Kidney
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The saline-treated control animals (saline) demonstrated a
steady rate of bodyweight gain (Figure 2). NB alone did not
significantly influence weight gain. Treatment with endotoxin at a
preconditioning dose (LPS(p)) induced about 20% bodyweight loss
within the first 3 days in all animals compared to animals not
receiving LPS. However, after 3–4 days, the animals started to
recover from the preconditioning dose of endotoxin (LPS(p)). All
animals treated with a lethal dose of LPS (LPS(L)) lost weight at a
faster rate than those mice treated with LPS(p) and died (Figure 2).
Treatment with a low dose of LPS induced delayed precondition-
ing as animals treated with a subsequent lethal dose of LPS
(LPS(p+L)) initially lost weight but recovered from day 5 after
treatment. If the lethal LPS dose was preceded with NB, all
animals lost weight and died within 3 days (NB+LPS(L)). Also, NB
administered simultaneously with the preconditioning dose of LPS
prevented delayed preconditioning as animals did not recover
from a subsequent treatment with LPS(L), but lost weight and died
(LPS/NB+LPS(L)) (Figure 2).
Novobiocin prevented preconditioning-induced
protection of renal function and histology
As a sign of endotoxin shock-induced renal failure serum urea
was elevated at 24 hours after the second injection (Figure 3).
Compared to the saline-treated control mice, NB alone did not
increase serum urea, i.e. it did not impair renal function. The
preconditioning dose of LPS (LPS(p)) induced a temporary but
significant elevation in serum urea. Preconditioning was obvious in
mice treated with a preconditioning and a subsequent lethal LPS
dose (LPS(p+L), as the preconditioning dose of LPS prevented the
increase in serum urea that was caused by the lethal LPS dose. NB
prevented preconditioning: a concomitant NB administration with
LPS(p) (LPS/NB+LPS(L)) resulted in a similar increase of serum
urea to that caused by the lethal LPS dose (Figure 3).
Renal histology was normal in mice treated with saline or NB
(Figure 4) as high cylindrical tubular epithelial cells and intact
brush border was observed on PAS-stained slides. Various degree
of tubular damage was obvious in all LPS-treated mice; however,
the histological damage index was low in mice treated with only a
preconditioning (LPS(p)) or a preconditioning and a subsequent
lethal dose of LPS (LPS(p+L). Preconditioning with a low dose of
LPS preserved renal morphology but the protective effect of
preconditioning was diminished by a simultaneous treatment with
NB (Figure 4).
Novobiocin inhibited LPS-induced Hsp70 and Hsp90
protein expression
In order to explore the molecular background of LPS-induced
preconditioning and how NB prevented preconditioning, we
investigated the effects of NB on heat shock protein expression
with Western blot analysis. The preconditioning dose of LPS
significantly stimulated (doubled) Hsp70 and Hsp90 (Figure 5)
expression compared to the saline-treated mice. NB administered
alone significantly reduced Hsp70 but not Hsp90 protein
expression vs. saline-treated mice. LPS(p)-induced stimulation of
Hsp70 and Hsp90 was inhibited by simultaneous administration of
NB.
Novobiocin increased Hsp90 mRNA expression and
prevented LPS-induced Hsp70 mRNA expression
To explore the mechanism of LPS-induced increase in HSP
protein expression, we measured Hsp70, Hsp90a and Hsp90b
mRNA levels by Northern blotting. LPS(p) significantly stimulated
Hsp90a and Hsp90b but not Hsp70 mRNA levels (Figure 6),
probably due to the HSF1-mediated transcriptional induction of
the heat shock response. Interestingly, NB also evoked a significant
induction of all HSP mRNAs. The stimulating effect of NB was
strongest in the case of Hsp70 mRNA and was similar to that of
LPS(p) in the cases of Hsp90a and Hsp90b. LPS(p)-evoked heat
shock response was not inhibited by NB at the mRNA level of
Hsp90a and Hsp90b. Neither were the Hsp90 stimulatory effects
of LPS and NB additive (Figure 6). In summary, NB treatment
stimulated Hsp70 and Hsp90 mRNA. Taken together with the
protein level studies, these results suggest that in the background of
diminished preconditioning LPS-induced Hsp70 and Hsp90
protein expression was inhibited by NB at the posttranscriptional
level.
Figure 2. Bodyweight. The control group treated with saline (saline)
is represented with filled circles and solid line, the group treated with
novobiocin (NB) is represented with filled squares and solid line, the
groups treated with LPS are represented with triangles and dashed line
(LPS(p)), solid line (LPS(L)) and dotted line (LPS(p+L)), the groups treated
with LPS + NB are represented with diamonds and solid line (NB +
LPS(L)) and dotted line (LPS/ND + LPS(L)).
doi:10.1371/journal.pone.0092004.g002
Figure 3. Plasma urea levels at the time of organ harvest i.e. at
24 hours after the second treatment. LPS: bacterial lipopolysac-
charide endotoxin, p: preconditioning, L: lethal, NB: novobiocin. *, **,
***: p,0.05, 0.01, 0.001 vs. the saline-treated controls, respectively, or
between the groups indicated.
doi:10.1371/journal.pone.0092004.g003
Hsp90-Dependent LPS Preconditioning in Mouse Kidney
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Discussion
In our previous study, repeated pretreatment with LPS
protected mice from a lethal renal ischemia/reperfusion injury
[12]. In the present study we demonstrated that treatment with a
preconditioning dose of LPS conferred protection from kidney
damage and consequent death caused by subsequent treatment
with a lethal dose of LPS. Further, we demonstrated that delayed
preconditioning with LPS was abrogated by concomitant treat-
ment with the Hsp90 inhibitor NB. This study provides evidence
that delayed preconditioning is accompanied by the induction of
heat shock proteins Hsp70 and Hsp90, and inhibition of Hsp90
function by NB prevents delayed preconditioning of the kidney.
Similarly to previous studies, we confirmed that LPS induced
acute renal failure [30], and this acute renal failure was the main
cause of death in mice treated with LPS.
Hsp70 was the first discovered heat shock protein [31] and is the
most ubiquitous and highly conserved HSP [32]. Heat shock
Figure 4. Representative photomicrographs and tubular damage index 24 hours after the second treatment. Photomicrographs: A)
Saline B) Novobiocin C) LPS(p), D) NB+LPS(L), E) LPS(L), F) LPS(p)+NB, G) LPS(p+L), H) LPS/NB+LPS(L). J) Tubular damage score (PAS, 400x). Arrows
indicate: dilatation of proximal tubules (red arrow), brush border loss (blue arrow), tubular casts (white arrow), neutrophil infiltration (black arrow).
LPS: bacterial lipopolysaccharide endotoxin, p: preconditioning, l: lethal, NB: novobiocin. *, **, ***: p,0.05, 0.01, 0.001 vs. the saline-treated controls,
respectively, or between the groups indicated.
doi:10.1371/journal.pone.0092004.g004
Figure 5. Western blot analysis of Hsp70 (A), and Hsp90 (B) protein expression. Results are normalized to actin protein expression, and
presented as fold increase relative to the saline-treated group with its mean set to 1. **, ***: p,0.01, 0.001 vs. the saline-treated controls, respectively,
or between the groups indicated (n = 6/group).
doi:10.1371/journal.pone.0092004.g005
Hsp90-Dependent LPS Preconditioning in Mouse Kidney
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protein family members assist protein folding and protect unfolded
chains from nonspecific interactions such as aggregation, and
proteins from damage and denaturation during cell stress such as
dehydration, temperature changes or hypoxia [33]. However,
HSPs are also necessary for the ubiquitination and breakdown of
damaged or misfolded proteins by the proteasome [34,35]. Thus,
HSPs are involved in both the creation, protection, maintenance
of protein homeostasis, but also the destruction of damaged
proteins. Hsp90 is a hub in the chaperone network maintaining
healthy protein turnover in cells upon insults such as endotoxin
shock [36].
Both Hsp70 and Hsp90 are present in the kidney [37] and
thought to play a central role in preconditioning [38]. The present
study corroborates these previous observations, as a precondition-
ing LPS dose induced Hsp70 and Hsp90 protein and Hsp90
mRNA expression in the renal tissue that later protected from an
otherwise lethal endotoxemia. A possible explanation for the lack
of Hsp70 mRNA upregulation, despite doubling of the Hsp70
protein level 24 hours after LPS treatment could be, that the
mRNA peak is earlier than investigated in the present study. In
previous studies, LPS-induced upregulation of Hsp70 and Hsp90
has been demonstrated in the blood of septic patients [39], or in
different organs such as the lung [40–42], skin [43] or
macrophages [44] of LPS-treated rodents. Similarly to our present
study, heat shock proteins were upregulated in the kidney upon
LPS treatment [38]. Furthermore, Hsp70 and Hsp90 protein
upregulation had a central protective role in preconditioning
against endotoxin shock [40,45]. Similarly to our results, local
upregulation of Hsp70 in the kidney and other organs during
preconditioning had a key role in protecting the kidney, lung and
liver from multi-organ failure [46]. On the other hand, exercise
preconditioning protected the kidney from IRI even in Hsp70 KO
mice [47], and pretreatment with monophosphoryl lipid A, an
endotoxin analogue, protected the heart from IRI in rabbits
without an increase in cardiac Hsp70 protein expression [48].
These data taken together with ours indicate that Hsp90 may be
more important mediator of preconditioning than Hsp70.
Furthermore, the involvement of Hsp mediated processes have
been reported recently in the background of other popular
preconditioning theories such as nitric oxide (NO) [49] or
regulatory T-cell mediated protection [50].
NB a well-known inhibitor of Hsp90 function inhibited LPS
induced Hsp70, and Hsp90 protein expression. These findings
corroborate previous reports and demonstrate a critical role of
Hsp90 in LPS signaling [18].
Moreover, NB antagonized the preconditioning-induced sur-
vival, amelioration of kidney morphology and function as well as
the stimulatory effects of LPS on Hsp70 and Hsp90 protein
expression. This inhibition of LPS-induced Hsp70 and Hsp90
protein upregulation may have been responsible for the prevention
of delayed preconditioning and death of mice after pretreatment
with NB. An intriguing finding is, that NB treatment alone
significantly stimulated Hsp70 and Hsp90 mRNA expression but
inhibited protein expression. NB a selective Hsp90 inhibitor might
inhibit Hsp70 protein post-transcriptionally by micro RNAs, as it
has been suggested that Hsp90 may be important in miRNA post-
transcriptional gene-expression regulation [51].
A recent review suggests that pharmacologic Hsp90 inhibitors
may protect the kidney from ischemia via the induction of the heat
shock response [25]. These results raise the idea that the heat
Figure 6. Northern blot analysis of Hsp70 (A), Hsp90a (B) and Hsp90b (C) mRNA expression. Results are normalized to S14 expression and
presented as fold increase relative to the saline-treated group with its mean set to 1. *, **, ***: p,0.05, 0.01, 0.001 vs. the saline-treated controls,
respectively, or between the groups indicated (n = 6/group).
doi:10.1371/journal.pone.0092004.g006
Hsp90-Dependent LPS Preconditioning in Mouse Kidney
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shock response is a mediator of preconditioning LPS treatment.
Further studies are needed to address this hypothesis. Importantly,
our study warns, that Hsp90 inhibitors, such as NB, that abrogate
the heat shock response should be used with caution in septic
patients with renal involvement.
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